-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Jasper Therapeutics to Hold

Benzinga·05/15/2026 16:45:34
Listen to the news
TD Cowen analyst Yaron Werber downgrades Jasper Therapeutics (NASDAQ:JSPR) from Buy to Hold.